Carlotta Zampieri, Kourosh Kouhmareh, Parnian Sartipdolagh, Pardis Azmoon, Richard L. Klemke, Steven L. Gonias. "The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma." Journal of Biological Chemistry, 2025. doi:10.1016/j.jbc.2025.110561